New pain drug tested in healthy volunteers

NCT ID NCT05721287

Summary

This early-stage study tested the safety of a new pain medication called SBS-1000 in healthy adults. Researchers gave increasing doses to 48 participants to see how their bodies handled the drug and to check for side effects. The goal was to determine safe dosage levels before testing in people with actual pain conditions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Altasciences Clinical Kansas

    Overland Park, Kansas, 66212, United States

Conditions

Explore the condition pages connected to this study.